Key facts
- Synthax (Business/Productivity Software)’s last known valuation is $7.6M (Oct 2025).
- It has raised $740K; the latest was Early Stage VC ($590K) in Oct 2025.
- Notable investors include Antler, Fuel Ventures, MountFund.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Synthax (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for Synthax (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synthax (Business/Productivity Software)
Developer of an artificial intelligence-powered operating system designed to automate administrative and clinical workflows in specialty clinics. The company offers AI agents for pre-screening, documentation, patient history management, and billing automation, enabling clinicians and healthcare providers to streamline operations, improve efficiency, and focus more on patient care.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 3
- Website
- synthax.ai/
- Ownership
- Privately Held (backing)
Synthax (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthax (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthax (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.